Developing Key Messages on Cancer for Commissioners

Similar documents
Developing Key Messages on Cancer for Commissioners

What are we aiming for?

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cost-effective commissioning of colorectal cancer care: An assessment of the cost-effectiveness of improving early diagnosis

Cancer Research UK response to All Party Parliamentary Group on Cancer consultation Cancer across the Domains

Progress in improving cancer services and outcomes in England. Report. Department of Health, NHS England and Public Health England

HC 568 SesSIon november Department of Health. Delivering the Cancer Reform Strategy

Ensuring effective commissioning of cancer services: A survey of GPs

National Cancer Update. Stephen Parsons Director

Number of people with diabetes

Commissioning Cancer Services. Andy McMeeking RCGP/NCIN Primary Care Workshop, 13 th February 2013

Defining quality in ovarian cancer services: the patient perspective

The Welsh Liberal Democrats plan to provide an effective cancer strategy for Wales

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME

NHS Diabetes Programme

Haemato-oncology Clinical Forum. 20 th June 2013

Six step guide to improving diabetes footcare. Putting feet. first

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

An Integrated National Strategy for Breast Cancer Audit. Martin Lee Gill Lawrence

Cancer Campaigning Group response to the consultation on the review of the Cancer Reform Strategy

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

WHERE NEXT FOR CANCER SERVICES IN NORTHERN IRELAND? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

NCIN Conference Feedback 2015

NHS Health Screening and Health Check Awareness for BME Communities in Trafford EXECUTIVE SUMMARY SAVING LIVES PROJECT MARCH 2016

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan

Cancer Screening Nottingham City Joint Strategic Needs Assessment April 2009

LOOKING BACK FROM THE

GOVERNING BODY MEETING in Public 22 February 2017 Agenda Item 3.4

National Cancer Programme. Work Plan 2015/16

Ambulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust

The Prime Minister s Challenge on Dementia. Lorraine Jackson Deputy Director: Domestic Dementia Policy Department of Health

Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network

NHS Wirral Clinical Commissioning Group Old Market House Hamilton Street Birkenhead Wirral CH41 5AL Tel:

RCGP and Cancer Research UK Workshop

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Wessex Cancer Alliance. Wessex Cancer Strategic Clinical Network

Helping Smokers Quit Clinicians adding value from every contact by treating tobacco dependence

RM Partners Accountable Cancer Network

Annual General Meeting

The role of cancer networks in the new NHS

Double Tree by Hilton Hotel Bellshill, ML4 3JQ 2 nd November 2017

The Idle Valley Ecominds project and commissioning experience. Dominic Higgins, Nature & Wellbeing Manager, The Wildlife Trusts

ELR CCG Annual General Meeting. Tuesday 26 September 2017

An Overview of Health Economics Data and Expertise in Cancer

RCGP and Cancer Research UK Workshop. Mercure Maidstone, Great Danes Hotel Maidstone ME17 1RE 19 th October 2017

Your pathway to success

Commissioning for Better Outcomes in COPD

NHS Southwark have advised SLaM of their commissioning intentions and requested that they restructure their services such that:

Pancreatic Cancer UK. policy briefing. Every Life Matters: the real cost of pancreatic cancer diagnoses via emergency admission

Understanding lymphoma: the importance of patient data

HC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme

Resource impact report: Eating disorders: recognition and treatment (NG69)

Commissioning for value focus pack

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

Advanced Competencies Helping Mental Health and Addiction Service Users Stop Smoking

Cancer in the South West Peninsula - a baseline assessment

National Optimal Lung Cancer Pathway

REPORT TO CLINICAL COMMISSIONING GROUP

FINANCE COMMITTEE DEMOGRAPHIC CHANGE AND AGEING POPULATION INQUIRY SUBMISSION FROM NATIONAL OSTEOPOROSIS SOCIETY

Healtheast CCG - developing an understanding of health and wellbeing needs. Public Health NHS Norfolk and Waveney Cluster and Norfolk County Council

Dr David Geddes. Head of Primary Care Commissioning. LDC Officials Day. 6 December 2013

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult)

Transforming Cancer Services for London

Progress on cancer survivorship. Stephen Hindle Cancer Survivorship Programme Lead

National Cancer Programme. Work Plan 2014/15

Lincolnshire JSNA: Cancer

NHS ENGLAND BOARD PAPER

Diabetes education: the big missed opportunity in diabetes care? Phaedra Perry Regional Head South West Katherine Calder Senior Policy Officer

NHS Right Care Deep Dive

Delivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Qualitative Analysis and Cost Benefit Modelling of Dementia Services George McNamara Alzheimer s Society

Leeds Cancer Strategy

Commissioning Guidance: Thames Valley & Milton Keynes Strategic Clinical Network. Cancer. September 2016

Our Plans for Improving Your Health

Public consultation: Seeking your views on IVF

BETTER CANCER CARE AND THE FUTURE PROVISION OF CANCER CARE IN NHS LANARKSHIRE

in North East Lincolnshire Care Trust Plus Implementation Plan Executive Summary

On-going and planned colorectal cancer clinical outcome analyses

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

Public Health England Dementia Intelligence Network. Dementia 2020 conference, 13 April 2017 Dr Charles Alessi, Senior Advisor, Public Health England

MCIP Recruitment Pack

National Breast Cancer Audit next steps. Martin Lee

Alliance Diagnostic Hub for NEL. Cancer Collaborative Annual Review event

FRAGILITY FRACTURE REGISTRY IN HONG KONG. Dr. WK NGAI COC (O&T), Hospital Authority

Improving Value in Chemotherapy

Evaluating endoscopy capacity across the NHS in England

Neurology data profiles

GMPOWER- Radically Reducing Smoking by One Third by 2020 Draft Plans Andrea Crossfield, CE, Healthier Futures 1

How to make changes in the NHS

Dementia in England. Dr Charles Alessi Senior Advisor on Dementia, Public Health England

Exercise & Sports Science Australia Submission: global action plan to promote physical activity

That the Single Commissioning Board supports the project outlined in this report and proceeds as described.

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead

Health Board/Region: All-Wales

PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire

Macmillan Cancer Support s offer to support the development of - Cancer information and support and benefits advice services for people affected by

Transcription:

Developing Key Messages on Cancer for Commissioners

Overarching messages (1) 1. NCIN/NCAT working with local cancer networks are keen to support GP commissioners to: Save lives Improve patients quality of life and experience of care Get optimal value for money 2. We can supply benchmarking information, together with expert interpretation, advice and support for implementation we are developing profiles at network, CCG, GP practice and Trust/team levels. We have a track record for delivery

Overarching messages (2) 3. Cancer patients are dying unnecessarily in all parts of the country (not just deprived areas). 10,000 deaths could be avoided each year in England if survival matched the best in Europe. The government has set a goal to save 5,000 lives p.a. each year by 2014/15. 4. On average a consortium serving 200,000 population would save 40 lives p.a. if our survival rates matched those in Australia, Sweden or Canada.

Overarching messages (3) 5. The NHS spends 6bn on cancer each year. Half of all expenditure relates to inpatient care (exclusive of surgery and exclusive of chemotherapy costs). 6. Investment in cancer services is currently inefficient we should redirect resources from inpatient care to earlier diagnosis.

Key recommendations for disinvestment Reduce emergency admissions by providing better proactive support (e.g. for patients on chemotherapy) and ambulatory services (e.g. for symptom control) Increase day case surgery Reduce lengths of stay through introduction of enhanced recovery programmes Reduce follow up through promotion of supported self management following primary treatment

Key recommendations for investment Invest in early diagnosis, especially: Public awareness campaigns Improved access to flexible sigmoidoscopy for patients with bowel symptoms which has been shown to prevent cancer and to be cost saving Improved access to chest xray (lung cancer) and ultrasound (especially pelvic for ovarian cancer)

Myths about cancer (1) 1. Myth 1: Cancer has had more than its fair share of the growth in NHS funding in recent years Wrong: cancer accounts for 6% of NHS budget and this has remained static 2. Myth 2: Too much attention has been given to cancer. We should turn our efforts to other conditions. Wrong: Survival rates following a diagnosis of cancer remain poor in England. Earlier diagnosis of cancer could save thousands of lives p.a.

Myths about cancer (2) 3. Myth 3: Cancer is a secondary and tertiary issue. It has little to do with primary and community care. Wrong: primary care has major roles in early diagnosis, ongoing support and end of life care for cancer patients. 4. Myth 4: All cancer interventions are highly expensive. Wrong: Many interventions with the greatest impact are highly cost effective (e.g. smoking cessation, screening, early diagnosis, surgery, radiotherapy and some curative chemotherapy). It is true that some chemotherapy given at the end of life is much less cost-effective. 5. Myth 5: Interventions for cancer only prolong life by a few months. Wrong: Upstream interventions (screening, early diagnosis and primary treatment) can make the difference between a long life and an early death.

What can commissioners do now? Invest in earlier diagnosis Ensure providers record stage (e.g. no staging, no payment!) Monitor the number of new cancer patients presenting as emergencies (currently 23%) and incentivise reductions Reduce emergency admissions of existing cancer patients through funding of proactive support. This will save money quickly. Seek advice from their cancer network

What can providers do now? Ensure diagnostic capacity, especially in endoscopy Establish proactive support (e.g. telephone contact) with patients on treatment Reduce lengths of stay for elective cancer surgery Day case/overnight breast surgery Enhanced recovery programmes

What can NCIN, NCAT and Networks do now? Provide intelligence and advice to commissioners Engage with providers on behalf of commissioners Take on direct commissioning functions for some aspects of cancer care (e.g. possibly RT and CT)

General messages on cancer (1) 1. The Incidence is rising: - 250,000 new cases p.a. now; 300,000 by 2030 2. Cancer services and outcomes (survival and mortality) have improved over the past 10 15 years. Much of the improvement has been in the hospital sector (MDTs etc) 3. Despite this, survival for many cancers remains poor in comparison with other developed countries 5000 lives a year could be saved if we matched the European average 10,000 lives a year could be saved if we achieved the level of the best 4. Late diagnosis is the major factor underlying the poor survival rates in this country

General messages on cancer (2) 5. This is not simply a matter of patients living a few extra months. It can often be the difference between early death and long term survival/cure 6. Initiatives to promote early diagnosis are likely to be highly cost effective 7. Particular attention should be given to: Reducing emergency presentations (23% of all cancers) as these have very poor survival The elderly who often present late Ensuring that providers record staging and report this to their cancer registry

Messages about individual cancers/interventions E.g. Breast cancer Bowel cancer Lung cancer Prostate cancer? Other cancers Radiotherapy Chemotherapy